A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma

NCT00590720 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

11

Enrollment

INDUSTRY

Sponsor class

Stopped Study is replaced by MI-CP198 per CPM.

Conditions

Asthma

Interventions

BIOLOGICAL: MEDI528 50 mg
OTHER: PLACEBO

Sponsor

MedImmune LLC